Dr. E. Premkumar Reddy and Colleagues

Professor and Director, Department of Oncological Sciences
Mount Sinai School of Medicine, New York, NY
Medicinal chemistry, cell cycle and molecular mechanism studies
Supported in part by SBIR Grants

Fels Institute
Clockwise, from back row: Drs. Ramana Reddy, Stephen Cosenza,
E. Premkumar Reddy, Nabisa Iqbal and Stacey Baker.


Dr. James F. Holland and Colleagues

Distinguished Professor of Neoplastic Diseases
Professor of Medicine, Hematology & Medical Oncology
Mount Sinai School of Medicine, New York, NY
Preclinical and Clinical Development of ON 01910.Na
Supported in part by the Martell Foundation

Mount Sinai school of Medicine
From Left: Drs. Takao Ohnuma, J.D. Jiang, James F. Holland,
John Roboz and Lewis Silverman


Dr. Jerome E. Groopman

Dina and Raphael Recanati Chair of Medicine, Harvard Medical School
Chief of Experimental Medicine
Beth Israel Deaconess Medical Center, Boston, MA
Cell Cycle-Directed Compounds for Mantle Cell Lymphoma
Supported in part by SBIR Grants

Jerome Groopman
Jerome Groopman, M.D.


Dr. Antonio Jimeno

Director, Developmental Therapeutics/Pharmacodynamic Laboratory
University of Colorado Cancer Center, Aurora, CO
Evaluation of ON 01910.Na in Head and Neck Cancer models
Gene expression signatures to predict activity in solid tumors

Dr. Antonio Jimeno
Antonio Jimeno, M.D., Ph.D.


Dr. Xavier Grana

Associate Professor of Biochemistry
Fels Institute for Cancer Research & Molecular Biology
Temple University School of Medicine
Philadelphia, PA 19140
Novel CDK inhibitors for HIV Therapy

Dr. Xavier Grana
Xavier Grana